March 2, 2020 / 2:42 PM / a month ago

BRIEF-Bridgebio Pharma Posts Qtrly Loss Per Share Of $0.62

March 2 (Reuters) - BridgeBio Pharma Inc:

* BRIDGEBIO PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND HIGHLIGHTS PORTFOLIO PROGRESS

* BRIDGEBIO PHARMA INC - QTRLY LOSS PER SHARE $0.62 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below